✦ LIBER ✦

Sargramostim: potential adjuvant therapy in melanoma?

Book ID: 120870373
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012400-00044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

348 Adjuvant therapy in melanoma

✍ A.M.M. Eggermont 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Adjuvant therapy of melanoma

✍ Sanjiv S. Agarwala; John M. Kirkwood 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

Patients with AJCC Stage IIB and III melanoma have a poor 5-year survival rate which has been the driving force behind attempts to find an effective adjuvant therapy for this stage of disease that would effectively reduce relapse and improve survival. Immunotherapy with bacillus Calmette-Guerin (BCG

Adjuvant therapy of melanoma

✍ Spyros Retsas 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 24 KB

Adjuvant therapy of melanoma

✍ A. Hauschild 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Interferon adjuvant therapy of melanoma

✍ Larry Nathanson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

Interferon adjuvant therapy of melanoma

✍ John M. Kirkwood; David Wazer; Maury Rosenstein 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views